✦ LIBER ✦

Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil

✍ Scribed by Marc Hazzan; François Provot; François Glowacki; Marie Christine Copin; Didier Roumilhac; Myriam Labalette; François Rene Pruvot; Christian Noel

Publisher: Springer
Year: 2004
Tongue: English
Weight: 180 KB
Volume: 17
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s00147-004-0739-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elective withdrawal of mycophenolate mof

Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone

✍ Cornelis G. ter Meulen; Peter J. H. Smak Gregoor; Willem Weimar; Luuk B. Hilbran 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 49 KB

Long-term efficacy and safety of mycophe

Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction

✍ Robert O. Koch; Ivo W. Graziadei; Frank Schulz; Karin Nachbaur; Alfred Königsrai 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 234 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil

✍ M. Brunet; J. Martorell; F. Oppenheimer; J. Vilardell; O. Millán; M. Carrillo; I 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 98 KB

Long-term renal function in liver transp

Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): The TRY study

✍ Svetlana Karie-Guigues; Nicolas Janus; Faouzi Saliba; Jerome Dumortier; Christop 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

The prevalence of renal insufficiency before and at 1, 12, and 60 months after liver transplantation (LTx; primary endpoint) and the changes in the glomerular filtration rate (GFR) at same time points according to the immunosuppressive regimen (coprimary endpoint) were investigated. The primary outc

Mycophenolate mofetil combination therap

Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C

✍ Russell H. Wiesner; Jolene S. Shorr; Bettina J. Steffen; Alice H. Chu; Robert D. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

To evaluate the impact of mycophenolate mofetil (MMF) on long-term outcomes of tacrolimus and corticosteroids, we analyzed data reported to the Scientific Registry of Transplant Recipients for 11,670 adult patients (3463 with hepatitis C [HCV]) who underwent primary, single-organ, liver transplantat